These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11860405)

  • 21. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia.
    Delgado-Aros S; Camilleri M; Cremonini F; Ferber I; Stephens D; Burton DD
    Gastroenterology; 2004 Dec; 127(6):1685-94. PubMed ID: 15578506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.
    Delvaux M; Louvel D; Mamet JP; Campos-Oriola R; Frexinos J
    Aliment Pharmacol Ther; 1998 Sep; 12(9):849-55. PubMed ID: 9768527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans.
    De Schepper H; Camilleri M; Cremonini F; Foxx-Orenstein A; Burton D
    Neurogastroenterol Motil; 2004 Oct; 16(5):567-73. PubMed ID: 15500513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alosetron does not affect the visceral perception of gastric distension in healthy subjects.
    Zerbib F; Bruley des Varannes S; Oriola RC; McDonald J; Isal JP; Galmiche JP
    Aliment Pharmacol Ther; 1994 Aug; 8(4):403-7. PubMed ID: 7986965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a test to measure gastric accommodation in humans.
    Kuiken SD; Samsom M; Camilleri M; Mullan BP; Burton DD; Kost LJ; Hardyman TJ; Brinkmann BH; O'Connor MK
    Am J Physiol; 1999 Dec; 277(6):G1217-21. PubMed ID: 10600819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health.
    Chial HJ; Camilleri C; Delgado-Aros S; Burton D; Thomforde G; Ferber I; Camilleri M
    Neurogastroenterol Motil; 2002 Jun; 14(3):249-53. PubMed ID: 12061909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography.
    Bouras EP; Delgado-Aros S; Camilleri M; Castillo EJ; Burton DD; Thomforde GM; Chial HJ
    Gut; 2002 Dec; 51(6):781-6. PubMed ID: 12427776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of magnetic resonance imaging to measure fasting and postprandial volumes in humans.
    Fidler J; Bharucha AE; Camilleri M; Camp J; Burton D; Grimm R; Riederer SJ; Robb RA; Zinsmeister AR
    Neurogastroenterol Motil; 2009 Jan; 21(1):42-51. PubMed ID: 19019018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological modulation of human gastric volumes demonstrated noninvasively using SPECT imaging.
    Liau SS; Camilleri M; Kim DY; Stephens D; Burton DD; O'Connor MK
    Neurogastroenterol Motil; 2001 Dec; 13(6):533-42. PubMed ID: 11903914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia.
    Talley NJ; Van Zanten SV; Saez LR; Dukes G; Perschy T; Heath M; Kleoudis C; Mangel AW
    Aliment Pharmacol Ther; 2001 Apr; 15(4):525-37. PubMed ID: 11284782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome.
    Camilleri M; Chey WY; Mayer EA; Northcutt AR; Heath A; Dukes GE; McSorley D; Mangel AM
    Arch Intern Med; 2001 Jul; 161(14):1733-40. PubMed ID: 11485506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review article: clinical pharmacology of alosetron.
    Gunput MD
    Aliment Pharmacol Ther; 1999 May; 13 Suppl 2():70-6. PubMed ID: 10429744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a role for gastric accommodation and satiety in asymptomatic obese people?
    Kim DY; Camilleri M; Murray JA; Stephens DA; Levine JA; Burton DD
    Obes Res; 2001 Nov; 9(11):655-61. PubMed ID: 11707531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers.
    Choung RS; Talley NJ; Peterson J; Camilleri M; Burton D; Harmsen WS; Zinsmeister AR
    Neurogastroenterol Motil; 2007 Mar; 19(3):180-7. PubMed ID: 17300287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the low-affinity, noncompetitive N-methyl-d-aspartate receptor antagonist dextromethorphan on visceral perception in healthy volunteers.
    Kuiken SD; Lei A; Tytgat GN; Holman R; Boeckxstaens GE
    Aliment Pharmacol Ther; 2002 Nov; 16(11):1955-62. PubMed ID: 12390105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans.
    Foxx-Orenstein A; Camilleri M; Stephens D; Burton D
    Gut; 2003 Nov; 52(11):1555-61. PubMed ID: 14570722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults.
    Andrews CN; Bharucha AE; Camilleri M; Low PA; Seide B; Burton D; Baxter K; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1359-65. PubMed ID: 17290009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid-induced colonic hypersensitivity in irritable bowel syndrome: the role of 5-HT3 receptors.
    Simrén M; Simms L; D'Souza D; Abrahamsson H; Björnsson ES
    Aliment Pharmacol Ther; 2003 Jan; 17(2):279-87. PubMed ID: 12534414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of glyceryl trinitrate on gastric accommodation and symptoms in functional dyspepsia.
    Gilja OH; Hausken T; Bang CJ; Berstad A
    Dig Dis Sci; 1997 Oct; 42(10):2124-31. PubMed ID: 9365147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study.
    Esfandyari T; Camilleri M; Ferber I; Burton D; Baxter K; Zinsmeister AR
    Neurogastroenterol Motil; 2006 Sep; 18(9):831-8. PubMed ID: 16918762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.